LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that more than 4 million Implantable Collamer® Lenses (ICLs) have been sold worldwide, marking a milestone in the global shift away from laser-based refractive surgery. This … [Read more…]

This evolution formalizes shared decision-making and collaboration to support patients accessing faster, more coordinated care, close to home MULLICA HILL, N.J.–(BUSINESS WIRE)–Inspira Health announced an enhanced shared decision-making structure designed to further strengthen “systemness” across the organization. Through smaller, cross-functional teams, the new leadership structure will provide additional opportunities for leaders to share learnings, align … [Read more…]

New patient-specific solution expands Catalyst’s portfolio, enabling precise translation of 3D surgical plans into the operating room to reduce steps and increase accuracy NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Archer® Patient-Specific … [Read more…]

– Announces Signing of Definitive Agreements to Divest the CDMO and Cell Solutions Businesses and Certain European Discovery Services Assets – – Updates 2026 Financial Guidance – WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has signed definitive agreements to sell certain European Discovery Services assets as well as the … [Read more…]

BASEL, Switzerland–(BUSINESS WIRE)–#ascensia–Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE: 6523), today announced the appointment of Peter Bodlund as President and Chief Executive Officer, effective April 1, 2026. He succeeds Koichiro Sato, who will continue in his roles as Chief Operating Officer of PHC Group and Head of … [Read more…]

Preclinical proof-of-concept data in GM2 gangliosidosis demonstrated survival benefit, functional improvement and target engagement Results are published in the 7 January issue of the Journal of Inherited Metabolic Disease Nizubaglustat is currently in Phase 3 registrational studies in GM1/GM2 gangliosidoses and Niemann-Pick type C disease (NPC) LEIDEN, Netherlands–(BUSINESS WIRE)–#Adults—Azafaros, a company aiming to become a … [Read more…]

Offering a New Option for Head and Neck Cancer Treatment TOKYO–(BUSINESS WIRE)–#cancer–HekaBio K.K., (Headquarters: Chuo-ku, Tokyo) announces that the innovative solid tumor treatment device ‘Alpha DaRT (Diffusing Alpha Radiation Therapy),’ developed by Alpha Tau Medical Ltd. (Headquarters: Jerusalem, Israel) has received official approval in Japan. HekaBio led the approval process as the Designated Marketing Authorization … [Read more…]

Kennedy brings seven years of public company CFO experience BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced that Keith Kennedy, the Company’s Chief Operating Officer (COO), will also … [Read more…]

Full Year 2025 Total Revenue of $380 Million Increased 14% Year-Over-Year Expects Full Year 2026 Revenue of $420 Million to $444 Million BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, … [Read more…]

NASHVILLE, Tenn.–(BUSINESS WIRE)–Envision today announced its refined direction and brand centered on clinicians and safeguarding the future of medicine. Providing great care is more than a job; it’s a calling. Envision’s purpose is Sustaining the Calling. “Behind every shift and every patient interaction is a clinician who felt called to serve,” said Jason Owen, President … [Read more…]